|
Variables
|
Number (%)
|
|---|
|
Gender
| |
|
Male
|
31 (27.2)
|
|
Female
|
83 (72.8)
|
|
Total
|
114 (100)
|
|
Age group (years)
| |
|
15 – 24
|
2 (1.7)
|
|
25 – 34
|
23 (20.2)
|
|
35+
|
89 (78.1)
|
|
Total
|
114 (100)
|
|
CD4 count
| |
|
<350
|
42 (36.8)
|
|
350 – 499
|
32 (28.1)
|
|
500+
|
40 (35.1)
|
|
Total
|
114 (100)
|
|
Duration of ART*(years)
| |
|
<2
|
38 (34.2)
|
|
2 – 4
|
30 (27.0)
|
|
5+
|
43 (38.7)
|
|
Total
|
111 (100)
|
|
NRTI** regimen
| |
|
AZT-based
|
75 (65.8)
|
|
D4T-based
|
4 (3.5)
|
|
TDF-based
|
35 (30.7)
|
|
Total
|
114 (100)
|
|
NNRTI** regimen
| |
|
EFV-based
|
54 (47.4)
|
|
NVP-based
|
60 (52.6)
|
|
Total
|
114 (100)
|
|
Smoking
| |
|
No
|
106 (94.6)
|
|
Yes
|
6 (5.4)
|
|
Total
|
112 (100)
|
|
Alcohol intake
| |
|
No
|
63 (56.2)
|
|
Yes
|
49 (43.5)
|
|
Total
|
112 (100)
|
|
Heart condition
| |
|
No
|
104 (93.7)
|
|
Yes
|
7 (6.3)
|
|
Total
|
111 (100)
|
|
Metabolic condition
| |
|
No
|
102 (91.9)
|
|
Yes
|
9 (8.1)
|
|
Total
|
111 (100)
|
|
Special diet
| |
|
No
|
101 (91.0)
|
|
Yes
|
10 (9.0)
|
|
Total
|
111 (100)
|
|
ART interruption
| |
|
No
|
107 (95.5)
|
|
Yes
|
5 (4.5)
|
|
Total
|
112 (100)
|
-
*
ART = antiretroviral therapy, **NRTI = nucleotide reverse transcriptase inhibitors, *** NNRTI = non-nucleotide reverse transcriptase inhibitor, AZT = zidovudine, 3TC = lamivudine, TDF = tenofovir, D4T = stavudine, EFV = efavirenz, NVP = nevirapine.
